Press release
Breast Cancer Drugs Market is projected to reach USD 57.1 billion by 2031 | Major Companies - Novartis AG, AbbVie, Inc., Eli Lilly and Company, AstraZeneca.
Breast Cancer Drugs Market
The Global Breast Cancer Drugs Market size reached USD 32.4 billion in 2024 and is projected to reach USD 57.1 billion by 2031, growing at a CAGR of 9.2% during the forecast period 2025-2031.
The Breast Cancer Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/breast-cancer-drugs-market?sz
The Breast Cancer Drugs Market encompasses pharmaceutical products designed to prevent, treat, or manage breast cancer by targeting hormone receptors, HER2 proteins, or cancer cell growth. It includes chemotherapies, hormone therapies, targeted therapies, and immunotherapies. Growth is driven by rising breast cancer incidence, advancements in personalized medicine, increasing awareness, and demand for more effective, less toxic treatment options worldwide.
Recent Key Developments of United States:
✅ December 2025: FDA approved Enhertu combined with Perjeta on December 15 for first-line HER2-positive advanced breast cancer, improving median progression-free survival to 40.7 months versus 26.9 months standard care.
✅ November 2025: FDA accepted supplemental application for Enhertu (trastuzumab deruxtecan) with paclitaxel, trastuzumab, and Perjeta for neoadjuvant HER2-positive stage II/III breast cancer, with PDUFA date in May 2026, signaling upcoming expansion. MSK-led research contributed to multiple 2025 FDA cancer approvals, advancing breast cancer options.
✅ October 2025: FDA approved imlunestrant (Inluriyo by Eli Lilly) on September 25, 2025 (announced October), for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer after endocrine therapy progression; it reduced progression or death risk by 38% in trials. Availability followed shortly after in the US market.
Recent Key Developments of Europe:
✅ December 2025: EMA overview updated for Enhertu in HER2-positive metastatic breast cancer around December 2, supporting expanded use in Europe.
✅ November 2025: EMA CHMP recommended imlunestrant (Inluriyo) for approval on November 13 as monotherapy for advanced/metastatic ER+/HER2- breast cancer, mirroring US progress. CHMP reviewed 10 new medicines overall, boosting oncology pipeline.
✅ October 2025: ESMO 2025 presented novel combination improving progression-free survival in metastatic ER-positive, HER2-negative breast cancer, influencing treatment strategies. EU4Health projects launched in September (active October) to advance AI in breast cancer screening and data integration via Cancer Image Europe.
List of the Key Players in the Breast Cancer Drugs Market:
Novartis AG
F. Hoffmann-La Roche Ltd.
AbbVie, Inc.
Eli Lilly and Company
AstraZeneca
Merck & Co., Inc.
Biocon Genzyme Corporation
MacroGenics Inc.
Janssen Global Services LLC
Onyx Pharmaceuticals Inc.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/breast-cancer-drugs-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Breast Cancer Drugs Market:
By Cancer Type: Metastatic Breast Cancer, Triple Negative Breast Cancer, Inflammatory Breast Cancer, Others.
By Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, Hormonal Therapy, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=breast-cancer-drugs-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Breast Cancer Drugs market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Breast Cancer Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Breast Cancer Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Breast Cancer Drugs Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Breast Cancer Drugs Market in 2025?
◆ What is the projected growth rate of the Breast Cancer Drugs Market through 2033?
◆ Who are the key players in the Breast Cancer Drugs Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Drugs Market is projected to reach USD 57.1 billion by 2031 | Major Companies - Novartis AG, AbbVie, Inc., Eli Lilly and Company, AstraZeneca. here
News-ID: 4333865 • Views: …
More Releases from DataM Intelligence 4Market Research
Dengue Vaccine Market Set to Soar: Innovations, Demand Surge, and Growth Opportu …
Market Overview:
The Dengue Vaccine Market is expected to grow at a CAGR of 10.4% during the forecast period 2024-2031.
The Dengue Vaccine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
Angiography Devices Market is expected to reach US$ 20.74 Billion by 2033 | Top …
Market Size and Growth:
The Global Angiography Devices Market size was US$ 12.94 Billion in 2024 and is expected to reach US$ 20.74 Billion by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.
The Angiography Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Antidepressant Drugs Market is expected to reach US$ 20.6 billion by 2031 | Majo …
Market Size and Growth:
The Global Antidepressant Drugs Market size reached US$ 14.3 billion in 2022 and is expected to reach US$ 20.6 billion by 2031, growing with a CAGR of 5.56% during the forecast period 2024-2031.
The Antidepressant Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Hunter Syndrome Treatment Market is expected to reach US$ 1,417.79million by 203 …
Market Size and Growth:
The Global Hunter Syndrome Treatment Market size reached US$ 747.06 million in 2024 and is expected to reach US$ 1,417.79million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
The Hunter Syndrome Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
